IONIS PHARMACEUTICALS INC shareholders Q3 2023

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.

IONIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
PROFUND ADVISORS LLC 35,470$1,608,9190.09%
FMR LLC 21,498,922$975,191,1010.08%
AXA S.A. 481,582$21,844,5600.08%
NBT BANK N A /NY 17,050$773,3880.07%
Verition Fund Management LLC 136,031$6,170,3660.07%
UBS OCONNOR LLC 62,059$2,814,9960.07%
SHERBROOKE PARK ADVISERS LLC 4,938$223,9880.07%
TWO SIGMA ADVISERS, LP 604,311$27,411,5470.07%
Hudson Bay Capital Management LP 380,000$17,236,8000.07%
WADDELL & ASSOCIATES, LLC 10,042$455,5050.07%
Leucadia National 160,210$7,267,1260.06%
FIRST TRUST ADVISORS LP 1,134,979$51,482,6470.06%
NOMURA HOLDINGS INC 459,311$20,834,3470.06%
TWO SIGMA INVESTMENTS, LP 476,057$21,593,9460.06%
Rafferty Asset Management, LLC 215,971$9,796,4450.06%
HRT FINANCIAL LP 114,600$5,1980.05%
Twin Lakes Capital Management, LLC 1,500$68,0400.05%
TD ASSET MANAGEMENT INC 898,852$40,771,9270.05%
China Universal Asset Management Co., Ltd. 3,670$1660.05%
Y-Intercept (Hong Kong) Ltd 8,803$399,3040.04%
External links

This page lists IONIS PHARMACEUTICALS INC's shareholders in Q3 2023. To view IONIS PHARMACEUTICALS INC's shareholder history, click here.